Dopo l'orario di chiusura: 16.99 0.010 +0.06%

MediWound Ltd (MDWD)

MediWound Ltd Borsa (MDWD) Ultime notizie

MediWound Ltd (MDWD)

MediWound Ltd Borsa (MDWD) Ultime notizie

MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Lifestyle UK

OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates

Investors in MediWound (NASDAQ:MDWD) have seen decent returns of 65% over the past year - Yahoo Finance

MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Canada Shine On

Trend Tracker for (MDWD) - Stock Traders Daily

StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell” - Defense World

Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates

MediWound (NASDAQ:MDWD) Upgraded to Sell by StockNews.com - MarketBeat

Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25% - Simply Wall St

Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25% - Simply Wall St

While institutions invested in MediWound Ltd. (NASDAQ:MDWD) benefited from last week's 16% gain, individual investors stood to gain the most - Simply Wall St

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences - Yahoo Finance

(MDWD) Technical Pivots with Risk Controls - Stock Traders Daily

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength? - Yahoo Finance

MDWD Stock Quote Price and Forecast - CNN

Shareholders in MediWound (NASDAQ:MDWD) have lost 61%, as stock drops 11% this past week - Simply Wall St

Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?

What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'

Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High? - Yahoo Finance

MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The ... - Yahoo Finance

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

MediWound Boasts Robust 2023 Financials and Growth - TipRanks.com - TipRanks

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates - Zacks Investment Research

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire

Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well - Yahoo Finance

MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?

Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates

Nexobrid: A revolutionary treatment for burns to treat patients in few hours - ETHealthWorld

Mediwound optimistic about wound therapy EscharEx after Phase II VLU trial - Clinical Trials Arena

Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the ... - GlobeNewswire

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx ... - GlobeNewswire

MediWound to Participate in Two Upcoming Investor Conferences

MediWound to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Ofer Gonen, Author at MedCity News - MedCity News

Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet

MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions

MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions - Zacks Investment Research

US Department of Defense funds MediWound's non-surgical burn treatment - BioPharma-Reporter.com

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. ... - Yahoo Finance

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to Trade

MediWound (NASDAQ:MDWD) investors are sitting on a loss of 75% if they invested five years ago - Yahoo Finance

Does MediWound (MDWD) Have the Potential to Rally 223.05% as Wall Street Analysts Expect?

MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

MediWound to Report Third Quarter 2023 Financial Results - Yahoo Finance

MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe - Yahoo Finance

Israel tops up budget for struggling biotechs amid continuing war challenges - BioWorld Online

Simile a MDWD